Sort
48,018 grants matching “immunotherapy”
TRAINING GRANT IN MOLECUCLAR IMAGING RESEARCH AND CANCER SYSTEMS ANALYSIS
$624,208Ralph Weissleder · Massachusetts General Hospital · T32 · FY2023 · CA
Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov
$624,179Protul Shrikant · Roswell Park Cancer Institute Corp · P50 · FY2017 · CA
Spatially resolved, single cell biomarkers of B cell lymphoma
$624,093Akil Merchant · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
$624,077Anaeze C Offodile · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Peptoid conjugates targeting prostate cancer
$624,001Michael J Garabedian · New York University School Of Medicine · R01 · FY2024 · CA
SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS
$624,000Research Institute At Nationwide Children'S Hospital · · FY2025 · Defense Health Agency
VAULT NANOPARTICLE IMMUNOTHERAPY FOR LUNG CANCER
$624,000University Of California, Los Angeles · · FY2018 · Department of the Army
IMPACT OF TUBERCULOSIS OF HIV INFECTION IN UGANDA
$623,961Case Western Reserve University · R01 · FY2002 · AI
Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy
$623,860Cheng Zhu · Georgia Institute Of Technology · U01 · FY2022 · CA
Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach
$623,838Todd A Aguilera · Ut Southwestern Medical Center · R01 · FY2024 · CA
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$623,825Max Wintermark · Stanford University · R01 · FY2020 · CA
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)
$623,822Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
$623,817Meenakshi G Hegde · Baylor College Of Medicine · R01 · FY2024 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Adoptive T Cell Therapy for Pancreatic Cancer
$623,803Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$623,787Paul E Kinahan · University Of Washington · U24 · FY2022 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2021 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2025 · CA
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
$623,722Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2022 · CA
Preclinical and Clinical Models of Drug Induced Kidney Injury
$623,715Melanie S Joy · University Of Colorado Denver · R01 · FY2025 · CA
Molecular Mechanisms of Adjuvant Triplet Combinations
$623,649Nicolas Chevrier · University Of Chicago · U01 · FY2021 · AI
A molecular toolbox for thermal control of programmed cell death in animals
$623,635Lukasz Bugaj · University Of Pennsylvania · R01 · FY2025 · EB
KIR and HLA effects in CNS paraneoplastic syndromes and related neuroimmune conditions
$623,609Emmanuel J Mignot · Stanford University · U01 · FY2024 · NS
Novel Approaches to CD33-Directed Radioimmunotherapy
$623,487Roland Bruno Walter · Fred Hutchinson Cancer Center · R37 · FY2023 · CA